Pathophysiology of Pulmonary Hypertension
Definition and Classification
- Pulmonary hypertension (PH) is defined as a mean pulmonary arterial pressure (mPAP) ≥25 mmHg at rest measured via right heart catheterization, with recent guidelines suggesting a redefinition threshold of >20 mmHg 1
- PH is classified into five major groups based on etiology, pathophysiology, and therapeutic approaches 2
Hemodynamic Classifications
- Pre-capillary PH is characterized by mPAP ≥25 mmHg with pulmonary wedge pressure (PWP) ≤15 mmHg and pulmonary vascular resistance (PVR) ≥3 Wood units 1, 2
- Post-capillary PH is characterized by mPAP ≥25 mmHg with PWP >15 mmHg 1
- Combined pre- and post-capillary PH is characterized by mPAP >20 mmHg, PAWP >15 mmHg, and PVR ≥3 Wood units 1
Pathophysiological Progression
- The pathophysiological sequence in PH typically involves increased pulmonary vascular resistance 2
- Right ventricular failure is a late-stage consequence of PH 3
Group-Specific Pathophysiology
- Group 1 (PAH) is characterized by pre-capillary PH with PVR >3 Wood units due to pulmonary arterial remodeling 2
- Group 2 (Left Heart Disease) is characterized by post-capillary PH with PCWP >15 mmHg due to backward transmission of elevated left atrial pressure 2
- Group 3 (Lung Diseases/Hypoxia) is characterized by PH due to alveolar hypoxia causing pulmonary vasoconstriction and vascular remodeling 2
- Group 4 (CTEPH) is characterized by persistent obstruction of pulmonary arteries following pulmonary embolism 2
- Group 5 (Unclear/Multifactorial) includes hematological disorders and systemic conditions with complex mechanisms 2
Clinical Implications of Pathophysiology
- The median life expectancy from diagnosis in patients with idiopathic PAH, before disease-specific therapy, was only 2.8 years 1